Manufactured Crisis: How Devastating Drug Price Increases Are Harming America's Seniors
The Senate Homeland Security and Governmental Affairs Committee has released a report, detailing U.S. Senator Claire McCaskill's years-long effort to investigate dramatic prescription drug price increases. From 2012 to 2017, the prices of many of the most popular brand-name drugs increased at nearly ten times the cost of inflation. The report looked at the top 20 most commonly prescribed brand-name drugs for older adults. Furthermore, the report finds that although 48 million fewer prescriptions were written for the top 20 most commonly prescribed brand-name drugs for older adults, total sales revenue resulting from these prescriptions increased by almost $8.5 billion during the same period.
Click here to read the report.